Publications by authors named "Caleb Bliss"

Claim this Profile
E
Erratum to "Visual Function Benefit After Treatment With Pegcetacoplan: Microperimetry Analysis From the Phase 3 OAKS Trial," [Am J Ophthalmol 2025; 273:119-129].
Usha Chakravarthy, Roy Schwartz, Robyn H Guymer, Frank G Holz, Aleksandra V Rachitskaya, Caleb Bliss

Am J Ophthalmol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegcetacoplan for the treatment of geographic atrophy due to age-related macular degeneration: a plain language summary of OAKS and DERBY clinical studies.
Jeffrey S Heier, Eleonora M Lad, Frank G Holz, Philip J Rosenfeld, Robyn H Guymer, Caleb Bliss

Immunotherapy· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visual Function Benefit After Treatment With Pegcetacoplan: Microperimetry Analysis From the Phase 3 Oaks Trial.
Usha Chakravarthy, Roy Schwartz, Robyn H Guymer, Frank G Holz, Aleksandra V Rachitskaya, Caleb Bliss

Am J Ophthalmol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of the Anti-mucosal Addressin Cell Adhesion Molecule-1 Antibody Ontamalimab in Patients with Moderate-to-Severe Ulcerative Colitis or Crohn's Disease.
Séverine Vermeire, Silvio Danese, William J Sandborn, Stefan Schreiber, Stephen Hanauer, Caleb Bliss

J Crohns Colitis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correspondence.
Caroline Baumal, Caleb Bliss, Daniel Jones, Ramiro Ribeiro

Retina· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
Jeffrey S Heier, Eleonora M Lad, Frank G Holz, Philip J Rosenfeld, Robyn H Guymer, Caleb Bliss

Lancet· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT II.
Walter Reinisch, William J Sandborn, Silvio Danese, Xavier Hébuterne, Maria Kłopocka, Caleb Bliss

J Crohns Colitis· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional impairment outcomes in clinical trials of different ADHD medications: post hoc responder analyses and baseline subgroup analyses.
David R Coghill, Tamara Werner-Kiechle, Sepehr Farahbakhshian, Caleb Bliss, Brigitte Robertson

Eur Child Adolesc Psychiatry· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlations Between Clinical Trial Outcomes Based on Symptoms, Functional Impairments, and Quality of Life in Children and Adolescents With ADHD.
David R Coghill, Alain Joseph, Vanja Sikirica, Mark Kosinski, Caleb Bliss

J Atten Disord· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinguishing the efficacy and sedative effects of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
Michael Huss, Keith McBurnett, Andrew J Cutler, Amaia Hervás, Caleb Bliss

Eur Neuropsychopharmacol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics and Treatment Response to Lisdexamfetamine Dimesylate Versus Placebo in Adults With Binge Eating Disorder: Analysis by Gender and Age.
Susan G Kornstein, Caleb Bliss, Judith Kando, Manisha Madhoo

J Clin Psychiatry· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis.
Melissa Palmer, Lee Jennings, Debra G Silberg, Caleb Bliss, Patrick Martin

BMC Pharmacol Toxicol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absorption, Distribution, Metabolism, and Excretion of [C]-Volixibat in Healthy Men: Phase 1 Open-Label Study.
Nicholas Siebers, Melissa Palmer, Debra G Silberg, Lee Jennings, Caleb Bliss

Eur J Drug Metab Pharmacokinet· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationships between clinical scales and binge eating days in adults with moderate to severe binge eating disorder in two Phase III studies.
Leslie Citrome, Judith C Kando, Caleb Bliss

Neuropsychiatr Dis Treat· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate.
David R Coghill, Tobias Banaschewski, Caleb Bliss, Brigitte Robertson, Alessandro Zuddas

CNS Drugs· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials.
Myra W Popejoy, David L Paterson, Daniel Cloutier, Jennifer A Huntington, Benjamin Miller, Caleb A Bliss

J Antimicrob Chemother· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections.
Eliana S Armstrong, Janelle A Mikulca, Daniel J Cloutier, Caleb A Bliss, Judith N Steenbergen

BMC Infect Dis· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of ceftolozane/tazobactam versus levofloxacin in the treatment of complicated urinary tract infections (cUTIs) caused by levofloxacin-resistant pathogens: results from the ASPECT-cUTI trial.
Jennifer A Huntington, George Sakoulas, Obiamiwe Umeh, Daniel J Cloutier, Judith N Steenbergen, Caleb Bliss

J Antimicrob Chemother· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of active injection drug use in a cohort of patients infected with hepatitis C virus.
Carrie Reed, Caleb Bliss, Sherri O Stuver, Timothy Heeren, Sheila Tumilty

Am J Public Health· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of a brief motivational intervention on unprotected sex and sex while high among drug-positive emergency department patients who receive STI/HIV VC/T and drug treatment referral as standard of care.
Edward Bernstein, Desiree Ashong, Timothy Heeren, Michael Winter, Caleb Bliss

AIDS Behav· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up after voluntary human immunodeficiency virus/sexually transmitted infection counseling, point-of-service testing, and referral to substance abuse treatment from the emergency department.
Edward Bernstein, Timothy Heeren, Michael Winter, Desiree Ashong, Caleb Bliss

Acad Emerg Med· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hangover sensitivity after controlled alcohol administration as predictor of post-college drinking.
Damaris J Rohsenow, Jonathan Howland, Michael Winter, Caleb A Bliss, Caroline A Littlefield

J Abnorm Psychol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients.
Harold L Lazar, Marie M McDonnell, Stuart Chipkin, Carmel Fitzgerald, Caleb Bliss

Ann Surg· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and predictors of acute kidney injury in an urban cohort of subjects with HIV and hepatitis C virus coinfection.
Shikha Garg, Melanie Hoenig, Erika M Edwards, Caleb Bliss, Timothy Heeren

AIDS Patient Care STDS· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hangover Predicts Residual Alcohol Effects on Psychomotor Vigilance the Morning After Intoxication.
Jonathan Howland, Damaris J Rohsenow, Caleb A Bliss, Alissa B Almeida, Tamara Vehige Calise

J Addict Res Ther· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis